Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hofman, Tomáš
192  Ergebnisse:
Personensuche X
?
1

IFNγ mediates the resistance of tumor cells to distinct NK ..:

Hofman, Tomáš ; Ng, Siu Wang ; Garcés-Lázaro, Irene...
Journal for ImmunoTherapy of Cancer.  12 (2024)  7 - p. e009410 , 2024
Link: https://doi.org/10.1136/..
 
?
2

Hepatitis D infection induces IFN-β-mediated NK cell activa..:

Groth, Christopher ; Maric, Jovana ; Garcés Lázaro, Irene...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Human ILC3 Exert TRAIL-Mediated Cytotoxicity Towards Cancer..:

Siegler, Jana-Julia ; Correia, Margareta P. ; Hofman, Tomáš...
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
4

Toll-like receptor dual-acting agonists are potent inducers..:

Janovec, Vaclav ; Hodek, Jan ; Clarova, Kamila...
Scientific Reports.  10 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
5

Expression of TIM-3 on Plasmacytoid Dendritic Cells as a Pr..:

Font-Haro, Albert ; Janovec, Vaclav ; Hofman, Tomas...
Viruses.  10 (2018)  4 - p. 154 , 2018
Link: https://doi.org/10.3390/..
 
?
6

The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Pl..:

Janovec, Vaclav ; Aouar, Besma ; Font-Haro, Albert...
Frontiers in Immunology.  9 (2018)  - p. , 2018
Link: https://doi.org/10.3389/..
 
?
7

Hepatitis D infection induces IFN-β-mediated NK cell activa..:

Groth, Christopher ; Maric, Jovana ; Garcés Lázaro, Irene...
https://freidok.uni-freiburg.de/data/242669.  , 2023
Link: https://freidok.uni-frei..
 
?
8

Human ILC3 Exert TRAIL-Mediated Cytotoxicity Towards Cancer..:

Siegler, Jana-Julia ; Correia, Margareta P ; Hofman, Tomáš...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921484/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Human ILC3 Exert TRAIL-Mediated Cytotoxicity Towards Cancer..:

Siegler, Jana-Julia ; Correia, Margareta P ; Hofman, Tomáš...
https://repository.publisso.de/resource/frl:6434749.  , 2022
Link: https://repository.publi..
 
?
10

Toll-like receptor dual-acting agonists are potent inducers..:

Janovec, Vaclav ; Hodek, Jan ; Clarova, Kamila...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-020-69614-7.  , 2020
Link: https://inserm.hal.scien..
 
?
11

Toll-like receptor dual-acting agonists are potent inducers..:

Janovec, Vaclav ; Hodek, Jan ; Clarova, Kamila...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-020-69614-7.  , 2020
Link: https://inserm.hal.scien..
 
?
12

Toll-like receptor dual-acting agonists are potent inducers..:

Janovec, Vaclav ; Hodek, Jan ; Clarova, Kamila...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-020-69614-7.  , 2020
Link: https://www.hal.inserm.f..
 
?
13

Toll-like receptor dual-acting agonists are potent inducers..:

Janovec, Vaclav ; Hodek, Jan ; Clarova, Kamila...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-020-69614-7.  , 2020
Link: https://inserm.hal.scien..
 
?
14

The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Pl..:

Janovec, Vaclav ; Aouar, Besma ; Font-Haro, Albert...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2018.00364.  , 2018
Link: https://hal.science/hal-..
 
?
15

The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Pl..:

Janovec, Vaclav ; Aouar, Besma ; Font-Haro, Albert...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835309/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
1-15